Table 1.
Clinical classification | Results of immunostaining | |||
---|---|---|---|---|
Total | INHBB negative | INHBB positive | P value | |
Age at surgery (years) | ||||
<70 | 48 | 21 | 27 | 0.4138 |
70< | 55 | 24 | 31 | |
Gender | ||||
Male | 58 | 25 | 33 | 0.1007 |
Female | 45 | 16 | 29 | |
T-primary tumor | ||||
T1 | 13 | 4 | 9 | |
T2 | 54 | 22 | 32 | |
T3 | 15 | 4 | 11 | |
T4 | 21 | 8 | 13 | |
T1+ T2 | 67 | 28 | 39 | 0.35900 |
T3+ T4 | 36 | 15 | 21 | |
N-regional lymph node | ||||
Negative | 60 | 38 | 22 | 0.00041* |
Positive | 43 | 9 | 34 | |
Stage | ||||
I | 13 | 3 | 10 | |
II | 41 | 16 | 25 | |
III | 18 | 6 | 12 | |
IV | 31 | 11 | 20 | |
I +Ⅱ | 54 | 19 | 35 | 0.4338 |
III + IV | 49 | 17 | 32 | |
Vascular invasion | ||||
Negative | 71 | 31 | 40 | 0.4380 |
Positive | 32 | 14 | 18 | |
Histopathologic type | ||||
Well differentiated | 64 | 25 | 39 | 0.2906 |
Moderately differentiated | 34 | 14 | 20 | |
Poorly differentiated | 5 | 2 | 3 |
*P < 0.05 is significant.